Camicold-Q Tablet
Bromhexine 4 mg + CPM 4 mg + Guaifenesin 50 mg Tablets — Mucolytic + Anti-Allergic Cough Therapy
| Composition | Bromhexine 4 mg + Chlorpheniramine Maleate (CPM) 4 mg + Guaifenesin 50 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 1300 |
| Therapy | Anti-Cold + G.P. — Mucolytic + Antihistamine + Expectorant |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Camicold-Q Tablet
Camicold-Q Tablet combines three respiratory actives: Bromhexine 4 mg (mucolytic), CPM 4 mg (antihistamine) and Guaifenesin 50 mg (expectorant) — for productive cough with mixed allergic and infective component. The triple action thins mucus, promotes its expectoration and reduces upper respiratory allergic symptoms simultaneously.
Bromhexine breaks down acid mucopolysaccharide fibres in mucus, reducing viscosity. Guaifenesin works as an expectorant by increasing the volume and decreasing the viscosity of bronchial secretions, easing their clearance. CPM provides antihistamine action for the allergic component frequently present in URI-associated cough.
Camicold-Q is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- Productive cough with thick mucus
- Cough with allergic component
- Acute bronchitis with mucus hypersecretion
- Post-URI persistent productive cough
- Cough associated with allergic rhinitis
Mechanism of Action
Bromhexine breaks disulphide bonds in mucoprotein fibres, reducing mucus viscosity. Guaifenesin stimulates respiratory tract secretions, lowering surface tension and viscosity of mucus to ease expectoration. CPM blocks H1 receptors, controlling histamine-mediated mucosal symptoms.
Dosage & Administration
Adults: 1 tablet three times daily for 5–7 days. Take with adequate fluids to enhance expectoration.
Side Effects
Drowsiness (CPM), GI upset, nausea, dry mouth. Rare hypersensitivity reactions.
Contraindications & Precautions
Hypersensitivity. Severe hepatic or renal impairment. MAOI use. Concurrent cough suppressants (counterproductive). Caution in elderly with cardiovascular disease.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Camicold-Q Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Camicold-Q Tablet used for?
Camicold-Q combines Bromhexine, CPM and Guaifenesin for productive cough with thick mucus and allergic component — particularly post-URI cough and acute bronchitis.
When should Camicold-Q be used?
Use when cough is productive (with mucus/phlegm). Avoid in dry/non-productive cough where mucolytics may worsen irritation.
Is Camicold-Q available for PCD pharma franchise?
Yes, on monopoly-based PCD pharma franchise and third-party manufacturing.
How should Camicold-Q be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Camicold-Q WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Camicold-Total Advance Tablet — Ambroxol 60 mg + Guaifenesin 50 mg + Phenylephrine 5 mg
- Ambrojoy Drops — Ambroxol Hydrochloride 7.5 mg / ml
- Bilastic-DP Syrup (Akums) — Dextromethorphan Hydrobromide 10 mg + Bilastine 3.3 mg per dose